CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

New England Journal of Medicine
Original article

Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty

Data ReadoutRivaroxabanAspirinNeutral
AI Analysis

Summary

New England Journal of Medicine publishes research comparing rivaroxaban followed by aspirin versus aspirin alone for thromboembolism prevention after total hip or knee arthroplasty. Insufficient detail provided to assess clinical significance or outcomes.

Clinical Trial Data

Importance:3/10
Sentiment:
0.00
clinical_trialNew England Journal of Medicineorthopedic_surgeryanticoagulation
Related Companies

Read the original article

Published by New England Journal of Medicine on July 12, 2026 9:15 AM

Read Original